Accurate prediction of myopic progression and high myopia by machine learning

IF 5.1 4区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Jiahui Li, Simiao Zeng, Zhihuan Li, Jie Xu, Zhuo Sun, Jing Zhao, Meiyan Li, Zixing Zou, Taihua Guan, Jin Zeng, Zhuang Liu, Wenchao Xiao, Ran Wei, Hanpei Miao, Ian Ziyar, Junxiong Huang, Yuanxu Gao, Yangfa Zeng, Xing-Tao Zhou, Kang Zhang
{"title":"Accurate prediction of myopic progression and high myopia by machine learning","authors":"Jiahui Li, Simiao Zeng, Zhihuan Li, Jie Xu, Zhuo Sun, Jing Zhao, Meiyan Li, Zixing Zou, Taihua Guan, Jin Zeng, Zhuang Liu, Wenchao Xiao, Ran Wei, Hanpei Miao, Ian Ziyar, Junxiong Huang, Yuanxu Gao, Yangfa Zeng, Xing-Tao Zhou, Kang Zhang","doi":"10.1093/pcmedi/pbae005","DOIUrl":null,"url":null,"abstract":"\n \n \n Myopia is a leading cause of visual impairment in Asia and worldwide. However, accurately predicting the progression of myopia and the high risk of myopia remains a challenge. This study aims to develop a predictive model for the development of myopia.\n \n \n \n We first retrospectively gathered 612 530 medical records from five independent cohorts, encompassing 227 543 patients ranging from infants to young adults. Subsequently, we developed a multivariate linear regression algorithm model to predict the progression of myopia and the risk of high myopia.\n \n \n \n The model to predict the progression of myopia achieved an R-squared (R2) value of 0.964 vs a mean absolute error (MAE) of 0.119D (95% CI: 0.119, 1.146) in the internal validation set. It demonstrated strong generalizability, maintaining consistent performance across external validation sets: R2 of 0.950 vs MAE of 0.119D (95% CI: 0.119, 1.136) in validation Study 1, R2 of 0.950 vs MAE of 0.121D (95% CI: 0.121, 1.144) in validation Study 2, and R2 of 0.806 vs MAE of −0.066D (95% CI: −0.066, 0.569) in Shanghai Children Myopia Study. Beijing Children Eye Study, the model sustained R2 of 0.749 vs MAE of 0.178D (95% CI: 0.178, 1.557). The model to predict the risk of high myopia achieved and an area under the curve (AUC) of 0.99 in the internal validation set and consistently high AUC values of 0.99, 0.99,0.96 and 0.99 in the respective external validation sets.\n \n \n \n Our study demonstrates accurate prediction of myopia progression and risk of high myopia providing valuable insights for tailoring strategies to personalize and optimize the clinical management of myopia in children.\n","PeriodicalId":33608,"journal":{"name":"Precision Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/pcmedi/pbae005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Myopia is a leading cause of visual impairment in Asia and worldwide. However, accurately predicting the progression of myopia and the high risk of myopia remains a challenge. This study aims to develop a predictive model for the development of myopia. We first retrospectively gathered 612 530 medical records from five independent cohorts, encompassing 227 543 patients ranging from infants to young adults. Subsequently, we developed a multivariate linear regression algorithm model to predict the progression of myopia and the risk of high myopia. The model to predict the progression of myopia achieved an R-squared (R2) value of 0.964 vs a mean absolute error (MAE) of 0.119D (95% CI: 0.119, 1.146) in the internal validation set. It demonstrated strong generalizability, maintaining consistent performance across external validation sets: R2 of 0.950 vs MAE of 0.119D (95% CI: 0.119, 1.136) in validation Study 1, R2 of 0.950 vs MAE of 0.121D (95% CI: 0.121, 1.144) in validation Study 2, and R2 of 0.806 vs MAE of −0.066D (95% CI: −0.066, 0.569) in Shanghai Children Myopia Study. Beijing Children Eye Study, the model sustained R2 of 0.749 vs MAE of 0.178D (95% CI: 0.178, 1.557). The model to predict the risk of high myopia achieved and an area under the curve (AUC) of 0.99 in the internal validation set and consistently high AUC values of 0.99, 0.99,0.96 and 0.99 in the respective external validation sets. Our study demonstrates accurate prediction of myopia progression and risk of high myopia providing valuable insights for tailoring strategies to personalize and optimize the clinical management of myopia in children.
通过机器学习准确预测近视发展和高度近视
近视是亚洲乃至全球视力受损的主要原因。然而,准确预测近视的发展和近视的高风险仍然是一项挑战。本研究旨在建立近视发展的预测模型。 我们首先回顾性地收集了来自五个独立队列的 612 530 份病历,其中包括 227 543 名从婴儿到青年的患者。随后,我们建立了一个多变量线性回归算法模型来预测近视的发展和高度近视的风险。 在内部验证集中,预测近视发展的模型的 R 平方 (R2) 值为 0.964,而平均绝对误差 (MAE) 为 0.119D (95% CI: 0.119, 1.146)。它具有很强的普适性,在外部验证集上保持了一致的性能:在验证研究 1 中,R2 为 0.950 vs MAE 为 0.119D (95% CI: 0.119, 1.136);在验证研究 2 中,R2 为 0.950 vs MAE 为 0.121D (95% CI: 0.121, 1.144);在上海儿童近视研究中,R2 为 0.806 vs MAE 为 -0.066D (95% CI: -0.066, 0.569)。在北京儿童眼科研究中,该模型的 R2 为 0.749,而 MAE 为 0.178D (95% CI: 0.178, 1.557)。预测高度近视风险的模型在内部验证集中的曲线下面积(AUC)达到了 0.99,在外部验证集中的曲线下面积(AUC)也分别达到了 0.99、0.99、0.96 和 0.99。 我们的研究证明了对近视发展和高度近视风险的准确预测,为定制个性化和优化儿童近视临床管理的策略提供了宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Precision Clinical Medicine
Precision Clinical Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
10.80
自引率
0.00%
发文量
26
审稿时长
5 weeks
期刊介绍: Precision Clinical Medicine (PCM) is an international, peer-reviewed, open access journal that provides timely publication of original research articles, case reports, reviews, editorials, and perspectives across the spectrum of precision medicine. The journal's mission is to deliver new theories, methods, and evidence that enhance disease diagnosis, treatment, prevention, and prognosis, thereby establishing a vital communication platform for clinicians and researchers that has the potential to transform medical practice. PCM encompasses all facets of precision medicine, which involves personalized approaches to diagnosis, treatment, and prevention, tailored to individual patients or patient subgroups based on their unique genetic, phenotypic, or psychosocial profiles. The clinical conditions addressed by the journal include a wide range of areas such as cancer, infectious diseases, inherited diseases, complex diseases, and rare diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信